[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"market-brand-preview-brazil":3,"market-product-preview-brazil":24,"related-news---Brazil":29},{"data":4,"market":5,"productCount":20,"indexableProductCount":20,"pagination":21},[],{"verifiedAt":6,"indexable":7,"slug":8,"name":9,"iso2":10,"region":11,"accessModels":12,"status":14,"summary":15,"purchaseRule":16,"regulator":17,"sourceLabel":18,"sourceUrl":19},"2026-08-27",true,"brazil","Brazil","BR","South America",[13],"medical_retail","Prescription cannabis products under ANVISA rules","ANVISA authorizes regulated cannabis products for human medical use, including pharmacy distribution and controlled import routes under the current framework.","Products require a prescription and must follow the product-specific controlled prescription and dispensing rules.","Agência Nacional de Vigilância Sanitária (ANVISA)","ANVISA — cannabis products framework","https:\u002F\u002Fwww.gov.br\u002Fanvisa\u002Fpt-br\u002Fassuntos\u002Fnoticias-anvisa\u002F2026\u002Fanvisa-publica-perguntas-e-respostas-sobre-a-autorizacao-sanitaria-de-produtos-de-cannabis\u002F",0,{"page":22,"limit":23,"total":20,"totalPages":22},1,6,{"data":25,"market":26,"pagination":28},[],{"verifiedAt":6,"indexable":7,"slug":8,"name":9,"iso2":10,"region":11,"accessModels":27,"status":14,"summary":15,"purchaseRule":16,"regulator":17,"sourceLabel":18,"sourceUrl":19},[13],{"page":22,"limit":23,"total":20,"totalPages":22},{"data":30,"pagination":31},[],{"page":22,"limit":32,"total":20,"pages":22},3]